Rocket Pharmaceuticals Inc (RCKT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -258,746 | -198,419 | -131,700 | -62,054 | -245,595 |
| Depreciation Amortization | 9,375 | 7,014 | 4,625 | 2,254 | 7,098 |
| Accounts payable and accrued liabilities | 6,067 | N/A | N/A | -2,413 | N/A |
| Other Working Capital | 5,671 | 4,511 | 1,579 | -5,665 | 13,822 |
| Other Operating Activity | 27,909 | 24,112 | 14,817 | 11,022 | 29,759 |
| Operating Cash Flow | $-209,724 | $-162,782 | $-110,679 | $-56,856 | $-194,916 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 175,130 | 94,623 | 101,016 | N/A |
| PPE Investments | -5,862 | -5,553 | -3,965 | -2,035 | -16,436 |
| Purchase Of Investment | -245,886 | N/A | N/A | -63,947 | -390,920 |
| Sale Of Investment | 383,454 | N/A | N/A | N/A | 309,326 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -36 |
| Investing Cash Flow | $131,706 | $169,577 | $90,658 | $35,034 | $-98,066 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 185,739 | 2,890 | 2,714 | 1,184 | 208,401 |
| Financing Cash Flow | $185,739 | $2,890 | $2,714 | $1,184 | $208,401 |
| Beginning Cash Position | 57,276 | 57,276 | 57,276 | 57,276 | 141,857 |
| End Cash Position | 164,997 | 66,961 | 39,969 | 36,638 | 57,276 |
| Net Cash Flow | $107,721 | $9,685 | $-17,307 | $-20,638 | $-84,581 |
| Free Cash Flow | |||||
| Operating Cash Flow | -209,724 | -162,782 | -110,679 | -56,856 | -194,916 |
| Capital Expenditure | -5,862 | -5,553 | -3,965 | -2,035 | -16,436 |
| Free Cash Flow | -215,586 | -168,335 | -114,644 | -58,891 | -211,352 |